NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-07-07
Reading CABR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CABR free→QuarterlyIQ Insights · CABR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| Dec 2025 | |
|---|---|
| Revenues | |
| Revenues | 0.0 |
| Total Revenues | 0.0 |
| Cost of Revenues | 0.0 |
| Gross Profit | 0.0 |
| Operating Expenses & Income | |
| Selling, General & Admin | 0.1 |
| R&D Expenses | 0.0 |
| Operating Income | (5.9) |
| Earnings from Continuing Operations | |
| Other Non-Operating Income / Expenses | (0.3) |
| Income Tax Expense | 0.0 |
| Net Income | |
| Net Income | (6.3) |
| Per Share | |
| Basic EPS | (0.46) |
| Diluted EPS | (0.46) |
| Basic Weighted Avg Shares | 13.6 |
| Diluted Weighted Avg Shares | 13.6 |
| Supplemental | |
| EBITDA | (5.6) |
| EBIT | (5.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
